The visit of the opening of the center for the participation of patients in the clinical trial of the drug Broncho-munal® P, capsules, 3.5 mg in the treatment of pediatric patients with acute uncomplicated respiratory tract infections was successfully completed, the study was sponsored by Sandoz.




























